The compound 2b was synthesized by the same procedure as
2a but using 4-bromo-2-hydroxybenzaldehyde instead of 5-
4. Experimental section
ACCEPTED MANUSCRIPT
4.1. General remarks
bromosalicylaldehyde. The product is yellow powder. Yield:
1
85%. H NMR (400 MHz, Chloroform-d), δ [ppm]: 14.17 (s,
All the reagents or chemicals were commercial products
without further purification. NMR spectra of the synthesized
compounds were recorded on Bruker AVANCE III instrument
(Bruker, Switzerland) and BRUKER Ascend 400. Mass spectra
analysis was recorded using a ThermoFisher LCQ Deca XP plus
instrument. Photophysical properties were investigated by a
Shimadzu UV-1800 spectrophotometer (Shimadzu, Japan) and a
Perkin-Elmer LS-55 luminescence spectrophotometer (the
integration time were set to be 0.01s in order to shorten the
measurement time to be less than 20s). The response toward F-
was conducted with tetrabutylammonium as counter cation
dissolved in a THF solution. The calculation method for
geometry optimization in the ground state is B3LYP/6-31G (d, p)
functional 37. The excited state calculations in this paper are
calculated using the TD-DFT// M06-2X/6-31+G (d, p) functional
38-40. All quantum chemical calculations were carried out using
1H), 8.80 (d, J = 8.3 Hz, 1H), 8.76-8.67 (m, 2H), 7.85-7.73 (m,
4H), 7.72 (ddd, J = 8.4, 7.0, 1.5 Hz, 1H), 7.68-7.62 (m, 2H), 7.56
(ddd, J = 8.3, 7.0, 1.3 Hz, 1H), 7.33 (d, J = 2.1 Hz, 1H), 7.30-
7.20 (t, 1H), 7.08 (d, J = 8.3 Hz, 1H), 6.67 (dd, J = 8.7, 2.1 Hz,
1H), 6.57 (d, J = 8.7 Hz, 1H). 13C NMR (126 MHz, Chloroform-
d), δ [ppm]: 160.03, 147.68, 138.72, 134.27, 131.01, 130.82,
129.56, 128.95, 128.48, 127.54, 127.08, 126.78, 126.60, 126.19,
125.57, 125.44, 124.21, 123.23, 122.53, 122.45, 121.30, 121.12,
120.85, 112.07. HRMS (ESI): m/z 465.0606 (M++1).
4.2.4. 2-(1-phenyl-1H-phenanthro[9,10-d]imidazol-2-yl)-4-
(1,2,2-triphenylvinyl)phenol (m-PITPE)
0.4 g (0.86 mmol) compound 2a, 0.4 g (1.05 mmol)
compound 1, 0.12 g K2CO3 and 0.02 g Pd(PPh3)4 catalyst were
added into a 50 mL two necked flask, and then 12 mL toluene
and 8 mL deionized water was added. The mixture was refluxed
for 24 h under N2 atmosphere. After cooling to room
temperature, the product was extracted with dichloromethane and
Gaussian 09 (version D.01) package on a PowerLeader cluster 41
.
4.2. Synthesis
purified
using
SiO2
column
chromatography
with
4.2.1. 4,4,5,5-tetramethyl-2-(1,2,2-triphenylvinyl)-1,3,2-
dichloromethane/petroleum ether (v/v, 1/2) as eluent to afford a
light yellow powder. Yield: 13%. 1H NMR (500 MHz,
Chloroform-d), δ [ppm]: 13.82 (s, 1H), 8.76 (d, J = 8.4 Hz, 1H),
8.73-8.67 (m, 2H), 7.77 (td, J = 7.5, 1.1 Hz, 2H), 7.69 (ddd, J =
8.4, 7.0, 1.5 Hz, 1H), 7.59-7.53 (m, 1H), 7.50 (ddd, J = 10.6, 8.8,
7.2 Hz, 3H), 7.39-7.35 (m, 2H), 7.22 (ddd, J = 8.3, 7.0, 1.2 Hz,
1H), 7.13-7.03 (m, 9H), 7.00 (dd, J = 8.5, 1.3 Hz, 1H), 6.91 (dt, J
= 5.7, 2.0 Hz, 5H), 6.87 (d, J = 8.4 Hz, 1H), 6.83-6.79 (m, 2H)
6.49 (d, J = 2.0 Hz, 1H). 13C NMR (126 MHz, Chloroform-d), δ
[ppm]: 157.91, 148.37, 143.90, 143.48, 143.43, 140.41, 140.07,
138.66, 134.28, 134.11, 133.77, 131.37, 131.33, 131.27, 130.89,
130.65, 130.29, 129.41, 129.32, 129.10, 128.58, 128.40, 127.60,
127.55, 127.50, 126.95, 126.48, 126.42, 126.30, 126.25, 126.04,
125.74, 125.22, 124.13, 123.21, 122.57, 120.86, 117.31, 112.47.
HRMS (ESI): m/z 641.2584 (M++1).
dioxaborolane (1)
1.0 g (3 mmol) (2-bromoethene-1,1,2-triyl)-tribenzene was
dissolved in 20 mL distilled THF at -78 under N2 atmosphere,
and then 3.0 mL (7.5 mmol) n-BuLi (1.6 M) was added dropwise
into the mixture. After stirred for 1 h, 2.2 mL (10.7 mmol) 2-
isopropoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane was added
dropwise into the mixture, and then the system was stirred for 8 h
under room temperature. The mixture was quenched with
saturated NH4Cl solution and extracted with dichloromethane.
After evaporation of the solvent, the product was purified by
SiO2 column chromatography with ethyl acetate/petroleum ether
1
(v/v, 50/1) as eluent to give a white solid. Yield: 70%. H NMR
(500 MHz, Chloroform-d), δ [ppm]: 7.37-7.29 (m, 5H), 7.17-7.03
(m, 8H), 6.99-6.93 (m, 2H), 1.13 (s, 12H). 13C NMR (126 MHz,
Chloroform-d), δ [ppm]: 151.38, 144.66, 141.83, 141.69, 130.92,
129.72, 129.42, 127.98, 127.94, 127.57, 127.51, 126.76, 125.84,
83.68, 24.55. MS (ESI): m/z 383.2 (M++1).
4.2.5. 2-(1-phenyl-1H-phenanthro[9,10-d]imidazol-2-yl)-5-
(1,2,2-triphenylvinyl)phenol (p-PITPE)
The compound p-PITPE was synthesized by the same
procedure as m-PITPE but using compound 2b instead of
compound 2a. The product is yellow powder. Yield: 44%. H
4.2.2. 4-bromo-2-(1-phenyl-1H-phenanthro[9,10-d]imidazol-2-
yl)phenol (2a)
1
NMR (500 MHz, Chloroform-d), δ [ppm]: 13.69 (s, 1H), 8.78 (d,
J = 8.3 Hz, 1H), 8.73-8.66 (m, 2H), 7.76 (ddd, J = 8.0, 7.0, 1.1
Hz, 1H), 7.73-7.66 (m, 4H), 7.62-7.57 (m, 2H), 7.52 ((ddd, J =
8.3, 7.0, 1.3 Hz, 1H), 7.27-7.23 (m, 1H), 7.15-6.98 (m, 15H),
6.83 (d, J = 1.8 Hz, 1H), 6.46 (d, J = 8.4 Hz, 1H), 6.20 (dd, J =
8.4, 1.8 Hz, 1H); 13C NMR (126 MHz, Chloroform-d), δ [ppm]:
158.59, 148.47, 146.44, 143.55, 143.41, 143.20, 141.68, 140.12,
138.98, 134.40, 131.32, 131.30, 131.15, 130.80, 130.52, 129.45,
129.05, 128.59, 128.42, 127.73, 127.68, 127.62, 127.50, 126.95,
126.69, 126.50, 126.05, 125.73, 125.21, 124.18, 123.20, 122.61,
122.58, 121.51, 120.86, 120.74, 111.27. HRMS (ESI): m/z
641.2584 (M++1).
0.56 g (2.4 mmol) 9,10-phenanthraquinone, 0.5 g (2.18 mmol)
5-bromosalicylaldehyde, 1.0 g (12 mmol) ammonium acetate and
0.30 mL aniline were added into a 100 mL two necked round-
bottom flask. 30mL acetic acid was added sequentially, and then
the mixture was heated at 120 for 12 h. After cooling to room
temperature, the product was extracted with dichloromethane and
purified
using
SiO2
column
chromatography
with
dichloromethane/ petroleum ether (v/v, 1/2) as eluent to afford a
1
white powder. Yield: 62%. H NMR (500 MHz, Chloroform-d),
δ [ppm]: 13.98 (s, 1H), 8.80 (d, J = 8.4 Hz, 1H), 8.75-8.68 (m,
2H), 7.88-7.84 (m, 1H), 7.83-7.76 (m, 3H), 7.73-7.69 (m, 1H),
7.68-7.62 (m, 2H), 7.59-7.53 (m, 1H), 7.34-7.28 (m, 2H), 7.18-
7.12 (m, 1H), 7.03 (d, J = 8.8 Hz, 1H), 6.75(d, J = 2.4 Hz, 1H).
13C NMR (126 MHz, Chloroform-d), δ [ppm]: 158.22, 147.00,
138.54, 134.27, 133.21, 131.07, 130.94, 129.63, 128.84, 128.66,
128.50, 127.58, 127.10, 126.63, 126.24, 125.60, 125.55, 124.21,
123.24, 122.54, 122.44, 120.94, 119.71, 114.53, 109.73. HRMS
(ESI): m/z 465.0607 (M++1).
Acknowledgments
This work was supported by China Postdoctoral Science
Foundation
(2018M632498),
the
Zhejiang
Provincial
Postdoctoral Fellowship (Z71101009), Zhejiang Provincial
Natural Science Foundation of China (LQ19E030016,
LY19E030006, LZ17E030001), and Natural Science Foundation
of China (51603185, 51673174, 21875219).We thank Dr.
Zhenghui Wu for his help.
4.2.3. 5-bromo-2-(1-phenyl-1H-phenanthro[9,10-d]imidazol-2-
yl)phenol (2b)